SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 167 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $13,085,000 | +3.6% | 218,625 | -20.7% | 0.96% | -3.2% |
| Q1 2018 | $12,626,000 | +4.2% | 275,675 | -9.3% | 1.00% | +12.3% |
| Q4 2017 | $12,114,000 | -7.9% | 303,995 | -7.6% | 0.89% | 0.0% |
| Q3 2017 | $13,158,000 | -23.6% | 328,945 | -17.7% | 0.89% | -13.0% |
| Q2 2017 | $17,220,000 | +7727.3% | 399,540 | +4389.2% | 1.02% | +9181.8% |
| Q3 2016 | $220,000 | -42.3% | 8,900 | -52.4% | 0.01% | -42.1% |
| Q2 2016 | $381,000 | -10.8% | 18,700 | -33.2% | 0.02% | -5.0% |
| Q1 2016 | $427,000 | -90.4% | 28,000 | -91.5% | 0.02% | -89.2% |
| Q4 2015 | $4,440,000 | -9.5% | 330,380 | -5.5% | 0.18% | -8.0% |
| Q3 2015 | $4,904,000 | -36.9% | 349,510 | -23.7% | 0.20% | -29.0% |
| Q2 2015 | $7,776,000 | – | 457,970 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 7,641,250 | $107,207,000 | 7.06% |
| HealthInvest Partners AB | 782,746 | $10,982,000 | 6.50% |
| KOPP INVESTMENT ADVISORS LLC | 729,960 | $10,241,000 | 5.51% |
| Murphy Michael R | 1,028,304 | $14,427,000 | 4.96% |
| Opaleye Management Inc. | 460,000 | $6,454,000 | 3.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 511,244 | $7,173,000 | 1.68% |
| Bruce & Co., Inc. | 394,581 | $5,535,000 | 1.42% |
| AlphaOne Investment Services, LLC | 235,065 | $3,297,000 | 1.40% |
| Ranger Investment Management | 1,560,453 | $21,893,000 | 1.23% |
| NORTHPOINTE CAPITAL LLC | 584,753 | $8,204,000 | 1.07% |